1,7-phenanthroline has been researched along with Cancer of Prostate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Paulson, DF; Ware, JL; Webb, KS | 1 |
EspaƱa, F; Estelles, A; Gilabert, J; Sanchez-Cuenca, J; Vera, CD | 1 |
Barczak, AK; Coyle, JT; Luthi-Carter, R; Speno, H | 1 |
Hioki, T; Hirano, K; Ishii, K; Sugimura, Y; Tatematsu, M; Usui, S; Yamamoto, H; Yoshida, S | 1 |
Chen, YR; Shrivastava, A; Tan, TH | 1 |
5 other study(ies) available for 1,7-phenanthroline and Cancer of Prostate
Article | Year |
---|---|
1,10-Phenanthroline reversibility inhibits proliferation of two human prostate carcinoma cell lines (PC-3 and DU145).
Topics: Antigens, Surface; Cell Division; Cell Line; DNA Replication; Epitopes; Humans; Kinetics; Male; Phenanthrolines; Prostatic Neoplasms; Thymidine | 1984 |
A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard.
Topics: Adult; Enzyme-Linked Immunosorbent Assay; Humans; Male; Phenanthrolines; Prostate-Specific Antigen; Prostatic Neoplasms; Protein C Inhibitor; Semen; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1993 |
Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.
Topics: Animals; Antigens, Surface; Binding, Competitive; Carboxypeptidases; Chelating Agents; Cloning, Molecular; Cobalt; Coumarins; Dipeptides; Edetic Acid; Folic Acid; Glutamate Carboxypeptidase II; Histamine H1 Antagonists; Humans; Hydrolysis; Isocoumarins; Kinetics; Leucine; Male; Neuropeptides; Pepstatins; Phenanthrolines; Prostatic Neoplasms; Protease Inhibitors; Rats; Serine Proteinase Inhibitors; Substrate Specificity; Synaptic Transmission; Tumor Cells, Cultured | 1998 |
Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion.
Topics: Amino Acid Sequence; CD13 Antigens; Copper; Dose-Response Relationship, Drug; Edetic Acid; Egtazic Acid; Enzyme Inhibitors; Epithelium; Humans; Immunohistochemistry; Leucine; Male; Neoplasm Invasiveness; Peptide Fragments; Phenanthrolines; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Substrate Specificity; Tumor Cells, Cultured; Zinc | 2001 |
Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate.
Topics: Antioxidants; Cells, Cultured; Chelating Agents; Down-Regulation; Drug Synergism; Dual-Specificity Phosphatases; Enzyme Activation; Humans; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Male; MAP Kinase Kinase 4; MAP Kinase Kinase 7; Metals; Mitogen-Activated Protein Kinase Kinases; Oxidative Stress; Phenanthrolines; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Pyrrolidines; Signal Transduction; Thiocarbamates; Ultraviolet Rays | 2001 |